For use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison’s disease). Desoxycortone pivalate prolonged-release suspension for injection. Each mL contains 25 mg desoxycortone pivalate, USP (equivalent to 19.9 mg/mL desoxycortone as base). Preservative: Chlorocresol, 1 mg/mL.